🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 16 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/06/2011 | 33,78 | 34,13 | 33,57 | 33,77 | +0,60% | 1,67% | 15.770.828 |
| 16/06/2011 | 33,53 | 33,74 | 33,40 | 33,57 | +0,03% | 1,02% | 10.610.057 |
| 15/06/2011 | 33,85 | 33,85 | 33,39 | 33,56 | -1,32% | 1,35% | 12.733.305 |
| 14/06/2011 | 33,88 | 34,24 | 33,71 | 34,01 | +0,88% | 1,55% | 13.224.607 |
| 13/06/2011 | 33,43 | 33,86 | 33,43 | 33,71 | -0,34% | 1,31% | 8.365.136 |
| 10/06/2011 | 34,24 | 34,24 | 33,74 | 33,83 | -1,53% | 1,45% | 12.472.248 |
| 09/06/2011 | 34,24 | 34,71 | 34,15 | 34,35 | +0,59% | 1,64% | 14.247.979 |
| 08/06/2011 | 33,90 | 34,30 | 33,85 | 34,15 | +0,62% | 1,35% | 12.646.635 |
| 07/06/2011 | 34,17 | 34,47 | 33,93 | 33,94 | +0,03% | 1,56% | 10.531.457 |
| 06/06/2011 | 34,06 | 34,19 | 33,86 | 33,93 | -0,73% | 0,95% | 10.100.310 |
| 03/06/2011 | 34,15 | 34,38 | 34,12 | 34,18 | -0,91% | 0,75% | 10.359.690 |
| 02/06/2011 | 34,52 | 34,59 | 34,28 | 34,49 | -0,28% | 0,88% | 11.086.478 |
| 01/06/2011 | 34,92 | 35,07 | 34,54 | 34,59 | -1,36% | 1,50% | 11.847.011 |
| 31/05/2011 | 34,72 | 35,08 | 34,68 | 35,07 | +1,49% | 1,15% | 15.506.732 |
| 27/05/2011 | 34,70 | 34,90 | 34,43 | 34,55 | -0,47% | 1,37% | 10.996.559 |
| 26/05/2011 | 35,01 | 35,11 | 34,45 | 34,71 | -0,84% | 1,91% | 17.826.794 |
| 25/05/2011 | 34,98 | 35,17 | 34,91 | 35,01 | -0,49% | 0,74% | 11.801.947 |
| 24/05/2011 | 35,20 | 35,34 | 35,11 | 35,18 | -0,08% | 0,68% | 12.074.742 |
| 23/05/2011 | 34,99 | 35,30 | 34,94 | 35,21 | -0,43% | 1,01% | 13.201.761 |
| 20/05/2011 | 35,67 | 35,76 | 35,20 | 35,36 | -0,86% | 1,58% | 11.870.696 |
| 19/05/2011 | 35,88 | 35,93 | 35,45 | 35,67 | -0,53% | 1,33% | 11.948.353 |
| 18/05/2011 | 35,54 | 35,90 | 35,41 | 35,86 | +0,83% | 1,37% | 13.604.822 |
| 17/05/2011 | 35,49 | 35,63 | 35,01 | 35,56 | -0,08% | 1,75% | 21.363.061 |
| 16/05/2011 | 35,36 | 35,84 | 35,31 | 35,59 | +0,59% | 1,51% | 19.638.682 |
| 13/05/2011 | 35,33 | 35,59 | 35,16 | 35,38 | -0,32% | 1,22% | 12.047.284 |
| 12/05/2011 | 35,02 | 35,56 | 34,90 | 35,50 | +1,56% | 1,88% | 16.706.692 |
| 11/05/2011 | 35,09 | 35,26 | 34,80 | 34,95 | -0,38% | 1,31% | 12.463.759 |
| 10/05/2011 | 34,88 | 35,11 | 34,83 | 35,09 | +0,79% | 0,79% | 10.061.743 |
| 09/05/2011 | 34,46 | 34,90 | 34,45 | 34,81 | +0,25% | 1,33% | 11.247.974 |
| 06/05/2011 | 34,86 | 35,07 | 34,63 | 34,72 | +0,39% | 1,26% | 13.386.733 |